Jennison Associates
MRK icon

Jennison Associates’s Merck MRK Stock Holding History

Jennison Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-681,200
Closed -$34.3M – 645
2015
Q4 		$34.3M Hold
681,200
– – 0.03% 349
2015
Q3 		$32.1M Buy
+681,200
New +$36.2M 0.03% 371

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates's MRK Position: Q2 2026 in Review

Jennison Associates reduced its Merck (MRK) stake by 56% in Q2 2026, selling an estimated $412M and leaving 2,728,958 shares worth $351M. The position accounts for 0.21% of the portfolio, ranked #59.

Jennison Associates first reported a position in MRK in Q2 2013 and has held it in 44 quarters since. The position peaked at $1.32B in Q1 2014. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Jennison Associates held 2,728,958 shares of Merck worth $351M as of Q2 2026.
  • Jennison Associates sold 3,520,379 Merck shares in Q2 2026, an estimated $412M.
  • Merck made up 0.21% of Jennison Associates's portfolio in Q2 2026, its #59 holding.
  • Jennison Associates first reported a position in Merck in Q2 2013 and has held it in 44 quarters since.
  • Jennison Associates's Merck position peaked at $1.32B in Q1 2014.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.